Suppr超能文献

在射血分数横跨整个范围的心力衰竭患者中,使用沙库巴曲缬沙坦治疗对利钠肽和逆重构的纵向变化。

Longitudinal Changes in Natriuretic Peptides and Reverse Cardiac Remodeling in Patients with Heart Failure Treated with Sacubitril/Valsartan Across the Left Ventricular Ejection Traction Spectrum.

机构信息

Department of Cardiology, Faculty of Medicine, University of Tsukuba.

Department of Cardiology, Graduate School of Comprehensive Human Sciences, University of Tsukuba.

出版信息

Int Heart J. 2023 Nov 30;64(6):1071-1078. doi: 10.1536/ihj.23-407. Epub 2023 Nov 14.

Abstract

Sacubitril/valsartan improves outcomes in patients with heart failure (HF) with reduced ejection fraction. However, the relationship between longitudinal changes in natriuretic peptides and echocardiographic parameters in patients with HF treated with sacubitril/valsartan across the left ventricular ejection fraction (LVEF) range is not fully understood.In patients with HF treated with sacubitril/valsartan, comprehensive data on natriuretic peptides, including atrial natriuretic peptide (ANP), N-terminal pro-brain-type natriuretic peptide (NT-proBNP), BNP, and echocardiography, were measured after 6 months of treatment. We assessed the change in natriuretic peptides and echocardiographic parameters in LVEF classification subgroups.Among 49 patients, the median ANP concentration increased from 55 pg/mL at baseline to 78 pg/mL (P < 0.001). The NT-proBNP concentration decreased from 250 pg/mL to 146 pg/mL (P < 0.001). No significant change was observed in the BNP concentration (P = 0.640). The trajectories of each natriuretic peptide in patients with LVEF > 40% (n = 22) were similar to those in individuals with LVEF ≤ 40% (n = 27). Regardless of LVEF classification, echocardiography at 6 months showed a significant improvement in LVEF, left ventricular end-diastolic volume, and the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity (E/e'). The reduction in natriuretic peptide concentration was related to LV reverse remodeling and decreased left and right atrial pressures assessed by E/e' and inferior vena cava diameter.Sacubitril/valsartan induced an increase in ANP, a reduction in NT-proBNP, and no change in plasma BNP, regardless of LVEF. It caused LV reverse remodeling, and the natriuretic peptide concentration changes were associated with structural and functional echocardiographic parameters.

摘要

沙库巴曲缬沙坦可改善射血分数降低的心力衰竭(HF)患者的结局。然而,在射血分数(LVEF)范围内接受沙库巴曲缬沙坦治疗的 HF 患者,其利钠肽和超声心动图参数的纵向变化之间的关系尚不完全清楚。在接受沙库巴曲缬沙坦治疗的 HF 患者中,在治疗 6 个月后测量了包括心房利钠肽(ANP)、N 末端脑利钠肽前体(NT-proBNP)、BNP 和超声心动图在内的综合利钠肽数据。我们评估了 LVEF 分类亚组中利钠肽和超声心动图参数的变化。在 49 例患者中,中位 ANP 浓度从基线时的 55 pg/mL 增加到 78 pg/mL(P < 0.001)。NT-proBNP 浓度从 250 pg/mL 下降至 146 pg/mL(P < 0.001)。BNP 浓度无显著变化(P = 0.640)。LVEF > 40%(n = 22)患者的每种利钠肽浓度变化轨迹与 LVEF ≤ 40%(n = 27)患者相似。无论 LVEF 分类如何,6 个月时的超声心动图显示 LVEF、左心室舒张末期容积和舒张早期二尖瓣血流速度与舒张早期二尖瓣环速度(E/e')的比值均有显著改善。利钠肽浓度的降低与 LV 逆重构以及 E/e'和下腔静脉直径评估的左、右心房压力降低有关。无论 LVEF 如何,沙库巴曲缬沙坦均可引起 ANP 增加、NT-proBNP 降低和血浆 BNP 无变化。它可引起 LV 逆重构,利钠肽浓度变化与结构和功能超声心动图参数相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验